Evaluation of Spasticity Treatment by Extracorporeal Shock Wave Therapy Using Utrasonographic Muscle Spasticity Measurement

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002582

Enrollment

Registered

2017-12-06

Start date

2016-11-30

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Extracorporeal shock wave therapy (ESWT) In the ESWT group, a single session of ESWT was given in the middle of muscle belly under ultrasound guidance at 4Hz, 2,000 shots with the in

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects were between the ages of 30 and 70 years old, could be treated with shock waves, had agreed to the treatment, had had a stroke at least three months prior to the study, and showed a Modified Ashworth Scale (MAS) score of the ankle exceeding one.

Exclusion criteria

Exclusion criteria: The exclusion criteria were as follow: history of surgical procedure in the lower extremity, ankle contracture or severe inflammatory arthritic diseases, history of local injection of botulinum toxin, phenol, or alcohol in the past three months.

Design outcomes

Primary

Measure	Time frame
Modified Ashworth Scale (MAS)	—

Secondary

Measure	Time frame
passive range of motion (PROM) of the ankle;Fugl-Meyer Assessment (FMA) of the lower limb ;Ultrasonographic assessment of medial gastrocnemius muscle and Achilles tendon architecture	—

Countries

Korea, Republic of

Contacts

Public ContactChang Han Lee

Gyeongsang National University Hospital

ychkhk1101@naver.com+82-55-750-9639

Outcome results